Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons
出版年份 2019 全文链接
标题
Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected persons
作者
关键词
Tuberculosis, Pregnancy, Drug research and development, Infants, HIV, Clinical trials, Drug therapy, Pediatrics
出版物
PLOS MEDICINE
Volume 16, Issue 8, Pages e1002882
出版商
Public Library of Science (PLoS)
发表日期
2019-08-16
DOI
10.1371/journal.pmed.1002882
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Advances in clinical trial design for development of new TB treatments: A call for innovation
- (2019) Christian Lienhardt et al. PLOS MEDICINE
- One Month of Rifapentine plus Isoniazid to Prevent HIV-Related Tuberculosis
- (2019) Susan Swindells et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug–Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine
- (2018) Kristina M Brooks et al. CLINICAL INFECTIOUS DISEASES
- Current status of pharmacokinetic and safety studies of multidrug-resistant tuberculosis treatment in children
- (2018) A. J. Garcia-Prats et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- State of the Art Review of HIV-TB coinfection in Special Populations
- (2018) Ethel D. Weld et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Two decades of off-label prescribing in children: a literature review
- (2018) Shamala Balan et al. World Journal of Pediatrics
- Sensitivity and specificity of WHO's recommended four-symptom screening rule for tuberculosis in people living with HIV: a systematic review and meta-analysis
- (2018) Yohhei Hamada et al. Lancet HIV
- Increasing the Participation of Pregnant Women in Clinical Trials
- (2018) Katrina Heyrana et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- High-dose rifampicin, moxifloxacin, and SQ109 for treating tuberculosis: a multi-arm, multi-stage randomised controlled trial
- (2017) Martin J Boeree et al. LANCET INFECTIOUS DISEASES
- Peripheral neuropathy in HIV-infected and uninfected patients in Rakai, Uganda
- (2017) Deanna Saylor et al. NEUROLOGY
- A Dose-Ranging Trial to Optimize the Dose of Rifampin in the Treatment of Tuberculosis
- (2015) Martin J. Boeree et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Population Pharmacokinetics of Rifampin in Pregnant Women with Tuberculosis and HIV Coinfection in Soweto, South Africa
- (2015) Paolo Denti et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Toward Earlier Inclusion of Pregnant and Postpartum Women in Tuberculosis Drug Trials: Consensus Statements From an International Expert Panel
- (2015) Amita Gupta et al. CLINICAL INFECTIOUS DISEASES
- Efavirenz Pharmacokinetics and Pharmacodynamics in HIV-Infected Persons Receiving Rifapentine and Isoniazid for Tuberculosis Prevention
- (2015) Anthony T. Podany et al. CLINICAL INFECTIOUS DISEASES
- Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR)
- (2015) Scott R. Evans et al. CLINICAL INFECTIOUS DISEASES
- Special Populations and Pharmacogenetic Issues in Tuberculosis Drug Development and Clinical Research
- (2015) Helen McIlleron et al. JOURNAL OF INFECTIOUS DISEASES
- Towards early inclusion of children in tuberculosis drugs trials: a consensus statement
- (2015) Sharon Nachman et al. LANCET INFECTIOUS DISEASES
- Designing Drug Trials: Considerations for Pregnant Women
- (2014) Jeanne S. Sheffield et al. CLINICAL INFECTIOUS DISEASES
- Pharmacokinetics of Efavirenz and Treatment of HIV-1 Among Pregnant Women With and Without Tuberculosis Coinfection
- (2014) Kelly E. Dooley et al. JOURNAL OF INFECTIOUS DISEASES
- Tuberculosis in children
- (2014) Ben J Marais JOURNAL OF PAEDIATRICS AND CHILD HEALTH
- Pregnancy and Infection
- (2014) Athena P. Kourtis et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Four-Month Gatifloxacin-Containing Regimen for Treating Tuberculosis
- (2014) Corinne S. Merle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Four-Month Moxifloxacin-Based Regimens for Drug-Sensitive Tuberculosis
- (2014) Stephen H. Gillespie et al. NEW ENGLAND JOURNAL OF MEDICINE
- High-Dose Rifapentine with Moxifloxacin for Pulmonary Tuberculosis
- (2014) Amina Jindani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pregnancy Differentially Impacts Performance of Latent Tuberculosis Diagnostics in a High-Burden Setting
- (2014) Jyoti S. Mathad et al. PLoS One
- Tuberculosis in pregnancy: an estimate of the global burden of disease
- (2014) Jordan Sugarman et al. Lancet Global Health
- Tuberculosis in Pregnant and Postpartum Women: Epidemiology, Management, and Research Gaps
- (2012) J. S. Mathad et al. CLINICAL INFECTIOUS DISEASES
- The Effect of HIV Infection, Immunodeficiency, and Antiretroviral Therapy on the Risk of Hepatic Dysfunction
- (2012) William J. Towner et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Reframing the Framework: Toward Fair Inclusion of Pregnant Women as Participants in Research
- (2011) Anne Drapkin Lyerly et al. AMERICAN JOURNAL OF BIOETHICS
- Tuberculosis Drug Development
- (2011) Anne F. Luetkemeyer et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Accuracy of the Xpert MTB/RIF test for the diagnosis of pulmonary tuberculosis in children admitted to hospital in Cape Town, South Africa: a descriptive study
- (2011) Mark P Nicol et al. LANCET INFECTIOUS DISEASES
- Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
- (2011) Timothy R. Sterling et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extrapolation of Adult Data and Other Data in Pediatric Drug-Development Programs
- (2011) J. Dunne et al. PEDIATRICS
- Drug Interactions Involving Combination Antiretroviral Therapy and Other Anti‐Infective Agents: Repercussions for Resource‐Limited Countries
- (2008) Kelly E. Dooley et al. JOURNAL OF INFECTIOUS DISEASES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started